APO Research
Talk to an analyst

APO RESEARCH · REPORT

Exportin 1

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Exportin 1 Market Outlook and Growth Opportunities 2026

2 January 2026198 pages

Choose your research edition.

Industry ResearchExportin 1 Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Exportin 1 Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Exportin 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exportin 1 Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Exportin 1 Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Exportin 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Exportin 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Exportin 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exportin 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Exportin 1 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Exportin 1 market include Biogen Inc, CanBas Co Ltd, Karyopharm Therapeutics Inc, Oita University Institute of Advanced Medicine Inc, Wigen Biomedicine Technology (Shanghai) Co Ltd and Jiangsu Carephar Pharmaceutical Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Exportin 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Exportin 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Exportin 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Exportin 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

Exportin 1 Segment by Company

Biogen Inc

CanBas Co Ltd

Karyopharm Therapeutics Inc

Oita University Institute of Advanced Medicine Inc

Wigen Biomedicine Technology (Shanghai) Co Ltd

Jiangsu Carephar Pharmaceutical Co Ltd

Exportin 1 Segment by Type

Chromosome Region Maintenance 1 Protein Homolog

XPO1

Exportin 1 Segment by Application

Oncology

Central Nervous System

Genetic Disorders

Immunology

Infectious Disease

Exportin 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Exportin 1 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Exportin 1 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Exportin 1 significant trends, drivers, influence factors in global and regions.

6. To analyze Exportin 1 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exportin 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exportin 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exportin 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Exportin 1 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Exportin 1 industry.

Chapter 3: Detailed analysis of Exportin 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Exportin 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Exportin 1 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Exportin 1 Industry Trends Table 2. Exportin 1 Industry Drivers Table 3. Exportin 1 Industry Opportunities and Challenges Table 4. Exportin 1 Industry Restraints Table 5. Global Exportin 1 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Exportin 1 Revenue Share by Company (2021-2026) Table 7. Global Exportin 1 Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Exportin 1 Sales Volume Share by Company (2021-2026) Table 9. Global Exportin 1 Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Exportin 1 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Exportin 1 Key Company Manufacturing Base & Headquarters Table 12. Global Exportin 1 Company, Product Type & Application Table 13. Global Exportin 1 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Exportin 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Chromosome Region Maintenance 1 Protein Homolog Table 18. Significant Companies of XPO1 Table 19. Global Exportin 1 Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Exportin 1 Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Exportin 1 Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Exportin 1 Sales Volume Share by Type (2021-2026) Table 23. Global Exportin 1 Sales Volume Share by Type (2027-2032) Table 24. Global Exportin 1 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Exportin 1 Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Exportin 1 Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Exportin 1 Sales Value Share by Type (2021-2026) Table 28. Global Exportin 1 Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Oncology Table 30. Significant Companies of Central Nervous System Table 31. Significant Companies of Genetic Disorders Table 32. Significant Companies of Immunology Table 33. Significant Companies of Infectious Disease Table 34. Global Exportin 1 Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Exportin 1 Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Exportin 1 Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Exportin 1 Sales Volume Share by Application (2021-2026) Table 38. Global Exportin 1 Sales Volume Share by Application (2027-2032) Table 39. Global Exportin 1 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Exportin 1 Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Exportin 1 Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Exportin 1 Sales Value Share by Application (2021-2026) Table 43. Global Exportin 1 Sales Value Share by Application (2027-2032) Table 44. Global Exportin 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Exportin 1 Sales by Region (2021-2026) & (K Units) Table 46. Global Exportin 1 Sales Market Share by Region (2021-2026) Table 47. Global Exportin 1 Sales by Region (2027-2032) & (K Units) Table 48. Global Exportin 1 Sales Market Share by Region (2027-2032) Table 49. Global Exportin 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Exportin 1 Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Exportin 1 Sales Value Share by Region (2021-2026) Table 52. Global Exportin 1 Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Exportin 1 Sales Value Share by Region (2027-2032) Table 54. Global Exportin 1 Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Exportin 1 Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Exportin 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Exportin 1 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Exportin 1 Sales by Country (2021-2026) & (K Units) Table 59. Global Exportin 1 Sales Market Share by Country (2021-2026) Table 60. Global Exportin 1 Sales by Country (2027-2032) & (K Units) Table 61. Global Exportin 1 Sales Market Share by Country (2027-2032) Table 62. Global Exportin 1 Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Exportin 1 Sales Value Market Share by Country (2021-2026) Table 64. Global Exportin 1 Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Exportin 1 Sales Value Market Share by Country (2027-2032) Table 66. Biogen Inc Company Information Table 67. Biogen Inc Business Overview Table 68. Biogen Inc Exportin 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Biogen Inc Exportin 1 Product Portfolio Table 70. Biogen Inc Recent Development Table 71. CanBas Co Ltd Company Information Table 72. CanBas Co Ltd Business Overview Table 73. CanBas Co Ltd Exportin 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. CanBas Co Ltd Exportin 1 Product Portfolio Table 75. CanBas Co Ltd Recent Development Table 76. Karyopharm Therapeutics Inc Company Information Table 77. Karyopharm Therapeutics Inc Business Overview Table 78. Karyopharm Therapeutics Inc Exportin 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Karyopharm Therapeutics Inc Exportin 1 Product Portfolio Table 80. Karyopharm Therapeutics Inc Recent Development Table 81. Oita University Institute of Advanced Medicine Inc Company Information Table 82. Oita University Institute of Advanced Medicine Inc Business Overview Table 83. Oita University Institute of Advanced Medicine Inc Exportin 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Oita University Institute of Advanced Medicine Inc Exportin 1 Product Portfolio Table 85. Oita University Institute of Advanced Medicine Inc Recent Development Table 86. Wigen Biomedicine Technology (Shanghai) Co Ltd Company Information Table 87. Wigen Biomedicine Technology (Shanghai) Co Ltd Business Overview Table 88. Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Product Portfolio Table 90. Wigen Biomedicine Technology (Shanghai) Co Ltd Recent Development Table 91. Jiangsu Carephar Pharmaceutical Co Ltd Company Information Table 92. Jiangsu Carephar Pharmaceutical Co Ltd Business Overview Table 93. Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Product Portfolio Table 95. Jiangsu Carephar Pharmaceutical Co Ltd Recent Development Table 96. Key Raw Materials Table 97. Raw Materials Key Suppliers Table 98. Exportin 1 Distributors List Table 99. Exportin 1 Customers List Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Exportin 1 Product Image Figure 2. Global Exportin 1 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exportin 1 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Exportin 1 Sales (2021-2032) & (K Units) Figure 5. Global Exportin 1 Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Exportin 1 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Chromosome Region Maintenance 1 Protein Homolog Image Figure 10. XPO1 Image Figure 11. Global Exportin 1 Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Exportin 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Exportin 1 Sales Volume Share by Type (2021-2032) Figure 14. Global Exportin 1 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Exportin 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Exportin 1 Sales Value Share by Type (2021-2032) Figure 17. Oncology Image Figure 18. Central Nervous System Image Figure 19. Genetic Disorders Image Figure 20. Immunology Image Figure 21. Infectious Disease Image Figure 22. Global Exportin 1 Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Exportin 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Exportin 1 Sales Volume Share by Application (2021-2032) Figure 25. Global Exportin 1 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Exportin 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Exportin 1 Sales Value Share by Application (2021-2032) Figure 28. Global Exportin 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Exportin 1 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Exportin 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Exportin 1 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Exportin 1 Sales Value (2021-2032) & (US$ Million) Figure 33. North America Exportin 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Exportin 1 Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Exportin 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Exportin 1 Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Exportin 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Exportin 1 Sales Value (2021-2032) & (US$ Million) Figure 39. South America Exportin 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Exportin 1 Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Exportin 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Exportin 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Exportin 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Exportin 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Exportin 1 Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Exportin 1 Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Chromosome Region Maintenance 1 Protein Homolog
  • XPO1
Applications
  • Oncology
  • Central Nervous System
  • Genetic Disorders
  • Immunology
  • Infectious Disease
Companies covered
  • Biogen Inc
  • CanBas Co Ltd
  • Karyopharm Therapeutics Inc
  • Oita University Institute of Advanced Medicine Inc
  • Wigen Biomedicine Technology (Shanghai) Co Ltd
  • Jiangsu Carephar Pharmaceutical Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Exportin 1 Sales Value (2021-2032)
  4. 1.2.2 Global Exportin 1 Sales Volume (2021-2032)
  5. 1.2.3 Global Exportin 1 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Exportin 1 Market Dynamics
  1. 2.1 Exportin 1 Industry Trends
  2. 2.2 Exportin 1 Industry Drivers
  3. 2.3 Exportin 1 Industry Opportunities and Challenges
  4. 2.4 Exportin 1 Industry Restraints
3 Exportin 1 Market by Company
  1. 3.1 Global Exportin 1 Company Revenue Ranking in 2025
  2. 3.2 Global Exportin 1 Revenue by Company (2021-2026)
  3. 3.3 Global Exportin 1 Sales Volume by Company (2021-2026)
  4. 3.4 Global Exportin 1 Average Price by Company (2021-2026)
  5. 3.5 Global Exportin 1 Company Ranking (2024-2026)
  6. 3.6 Global Exportin 1 Company Manufacturing Base and Headquarters
  7. 3.7 Global Exportin 1 Company Product Type and Application
  8. 3.8 Global Exportin 1 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Exportin 1 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Exportin 1 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Exportin 1 Market by Type
  1. 4.1 Exportin 1 Type Introduction
  2. 4.1.1 Chromosome Region Maintenance 1 Protein Homolog
  3. 4.1.2 XPO1
  4. 4.2 Global Exportin 1 Sales Volume by Type
  5. 4.2.1 Global Exportin 1 Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Exportin 1 Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Exportin 1 Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Exportin 1 Sales Value by Type
  9. 4.3.1 Global Exportin 1 Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Exportin 1 Sales Value by Type (2021-2032)
  11. 4.3.3 Global Exportin 1 Sales Value Share by Type (2021-2032)
5 Exportin 1 Market by Application
  1. 5.1 Exportin 1 Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Central Nervous System
  4. 5.1.3 Genetic Disorders
  5. 5.1.4 Immunology
  6. 5.1.5 Infectious Disease
  7. 5.2 Global Exportin 1 Sales Volume by Application
  8. 5.2.1 Global Exportin 1 Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Exportin 1 Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Exportin 1 Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Exportin 1 Sales Value by Application
  12. 5.3.1 Global Exportin 1 Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Exportin 1 Sales Value by Application (2021-2032)
  14. 5.3.3 Global Exportin 1 Sales Value Share by Application (2021-2032)
6 Exportin 1 Regional Sales and Value Analysis
  1. 6.1 Global Exportin 1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Exportin 1 Sales by Region (2021-2032)
  3. 6.2.1 Global Exportin 1 Sales by Region: 2021-2026
  4. 6.2.2 Global Exportin 1 Sales by Region (2027-2032)
  5. 6.3 Global Exportin 1 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Exportin 1 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Exportin 1 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Exportin 1 Sales Value by Region (2027-2032)
  9. 6.5 Global Exportin 1 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Exportin 1 Sales Value (2021-2032)
  12. 6.6.2 North America Exportin 1 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Exportin 1 Sales Value (2021-2032)
  15. 6.7.2 Europe Exportin 1 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Exportin 1 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Exportin 1 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Exportin 1 Sales Value (2021-2032)
  21. 6.9.2 South America Exportin 1 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Exportin 1 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Exportin 1 Sales Value Share by Country, 2025 VS 2032
7 Exportin 1 Country-level Sales and Value Analysis
  1. 7.1 Global Exportin 1 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Exportin 1 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Exportin 1 Sales by Country (2021-2032)
  4. 7.3.1 Global Exportin 1 Sales by Country (2021-2026)
  5. 7.3.2 Global Exportin 1 Sales by Country (2027-2032)
  6. 7.4 Global Exportin 1 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Exportin 1 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Exportin 1 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Exportin 1 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Exportin 1 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Exportin 1 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Exportin 1 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Exportin 1 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Exportin 1 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Exportin 1 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Exportin 1 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Exportin 1 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Exportin 1 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Exportin 1 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Exportin 1 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Exportin 1 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Exportin 1 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Exportin 1 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Exportin 1 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Exportin 1 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Exportin 1 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Exportin 1 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Exportin 1 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Exportin 1 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Exportin 1 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Exportin 1 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Exportin 1 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Exportin 1 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Exportin 1 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Exportin 1 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Exportin 1 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Exportin 1 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Exportin 1 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Exportin 1 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Exportin 1 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Exportin 1 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Exportin 1 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Exportin 1 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Exportin 1 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Exportin 1 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Exportin 1 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Exportin 1 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Exportin 1 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Exportin 1 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Exportin 1 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Exportin 1 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Exportin 1 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Exportin 1 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Exportin 1 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Exportin 1 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Exportin 1 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Exportin 1 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Exportin 1 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Exportin 1 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Exportin 1 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Exportin 1 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Exportin 1 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Exportin 1 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Exportin 1 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Exportin 1 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Exportin 1 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Exportin 1 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Exportin 1 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Exportin 1 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Exportin 1 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Exportin 1 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Exportin 1 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Exportin 1 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Exportin 1 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Exportin 1 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Exportin 1 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Exportin 1 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Exportin 1 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Exportin 1 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Exportin 1 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Exportin 1 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Exportin 1 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Exportin 1 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Exportin 1 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Exportin 1 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Exportin 1 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Exportin 1 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Exportin 1 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Exportin 1 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Exportin 1 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Exportin 1 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Exportin 1 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Biogen Inc
  2. 8.1.1 Biogen Inc Company Information
  3. 8.1.2 Biogen Inc Business Overview
  4. 8.1.3 Biogen Inc Exportin 1 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Biogen Inc Exportin 1 Product Portfolio
  6. 8.1.5 Biogen Inc Recent Developments
  7. 8.2 CanBas Co Ltd
  8. 8.2.1 CanBas Co Ltd Company Information
  9. 8.2.2 CanBas Co Ltd Business Overview
  10. 8.2.3 CanBas Co Ltd Exportin 1 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CanBas Co Ltd Exportin 1 Product Portfolio
  12. 8.2.5 CanBas Co Ltd Recent Developments
  13. 8.3 Karyopharm Therapeutics Inc
  14. 8.3.1 Karyopharm Therapeutics Inc Company Information
  15. 8.3.2 Karyopharm Therapeutics Inc Business Overview
  16. 8.3.3 Karyopharm Therapeutics Inc Exportin 1 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Karyopharm Therapeutics Inc Exportin 1 Product Portfolio
  18. 8.3.5 Karyopharm Therapeutics Inc Recent Developments
  19. 8.4 Oita University Institute of Advanced Medicine Inc
  20. 8.4.1 Oita University Institute of Advanced Medicine Inc Company Information
  21. 8.4.2 Oita University Institute of Advanced Medicine Inc Business Overview
  22. 8.4.3 Oita University Institute of Advanced Medicine Inc Exportin 1 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Oita University Institute of Advanced Medicine Inc Exportin 1 Product Portfolio
  24. 8.4.5 Oita University Institute of Advanced Medicine Inc Recent Developments
  25. 8.5 Wigen Biomedicine Technology (Shanghai) Co Ltd
  26. 8.5.1 Wigen Biomedicine Technology (Shanghai) Co Ltd Company Information
  27. 8.5.2 Wigen Biomedicine Technology (Shanghai) Co Ltd Business Overview
  28. 8.5.3 Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Product Portfolio
  30. 8.5.5 Wigen Biomedicine Technology (Shanghai) Co Ltd Recent Developments
  31. 8.6 Jiangsu Carephar Pharmaceutical Co Ltd
  32. 8.6.1 Jiangsu Carephar Pharmaceutical Co Ltd Company Information
  33. 8.6.2 Jiangsu Carephar Pharmaceutical Co Ltd Business Overview
  34. 8.6.3 Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Product Portfolio
  36. 8.6.5 Jiangsu Carephar Pharmaceutical Co Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Exportin 1 Value Chain Analysis
  2. 9.1.1 Exportin 1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Exportin 1 Sales Mode & Process
  6. 9.2 Exportin 1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Exportin 1 Distributors
  9. 9.2.3 Exportin 1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst